Policies and guidelines

High business ethics and personal integrity ensure the company’s credibility and reputation.

Information policy

Nobel Biocare pursues an open and active information policy for the benefit of both the financial markets and the general public. All stakeholders should be given the same opportunity to follow Group developments. Publications are made available to all stakeholders at the same time. Nobel Biocare’s reporting and transparency surpasses legal requirements. Investor Relations (IR) is a staff function at Nobel Biocare and reports to the CFO, while the CEO holds ultimate responsibility for all external information to the financial community. The IR Department has the task of continuously providing factual, relevant information to shareholders and the stock market. The Board of Directors has issued guidelines to ensure that investors will be informed in a timely and appropriate fashion in compliance with the rules specified in registration contracts with the SIX Swiss Exchange.

Insider trading policy

In order to prevent insiders from benefiting from confidential information, the Board of Directors issued guidelines on how to deter both corporate insiders and external consultants from making use of confidential information. The Board of Directors has established so-called blocking periods to prevent insiders from trading during sensitive periods. The Board of Directors approved and implemented an amended Insider Directive with effect 25 September 2008, which is in compliance with the EU directive on Market Abuse.

Whistleblowing

The global whistleblower hotline was used as intended and managed as designed. All staff and managers have access to independent and neutral communication channels to report potential non-compliance with laws, regulations, as well as internal and external business standards. No major cases were reported. The number of cases remained almost unchanged from the previous year and is in line with international benchmarks.

Code of conduct

Our Code of conduct is one of many tools we provide our employees to help them meet our legal and ethical obligations. It is comprehensive in scope, covering business practice, corporate governance, patient health and safety, conflicts of interest, insider information, competition laws, bribery, gifts and donations, property, equality, records, confidentiality, intellectual property and environmental law. All employees must sign and abide by the Code, which is available in various languages. In addition to the Code of Conduct, our actions are guided by various other policies, including an environmental policy, a quality policy and a staffing policy. In 2011, we launched a global staffing policy and an employee handbook for our HQ in Switzerland.

Investor contacts

Süha Demokan

Süha Demokan

Head of Investor Relations

Nobel Biocare Management AG  
P.O. Box
CH - 8058 Zurich-Airport
Switzerland

+41 43 211 42 30

+41 79 430 81 46

+41 43 211 42 42

Give us your feedback!

Summarize your comments
Email